Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cells

por Manteniotis, S, Wojcik, S, Göthert, J R, Dürig, J, Dührsen, U, Gisselmann, G, Hatt, H
Publicado 2016

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry

por Kaifie, A., Kirschner, M., Wolf, D., Maintz, C., Hänel, M., Gattermann, N., Gökkurt, E., Platzbecker, U., Hollburg, W., Göthert, J. R., Parmentier, S., Lang, F., Hansen, R., Isfort, S., Schmitt, K., Jost, E., Serve, H., Ehninger, G., Berdel, W. E., Brümmendorf, T. H., Koschmieder, S.
Publicado 2016

P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET)

por Palandri, F., Ross, D. M., Cochrane, T., Tate, C., Lane, S. W., Larsen, S. R., Gerds, A. T., Halpern, A. B., Shortt, J., Rossetti, J. M., Pettit, K. M., Liang, J., Mead, A., Marchetti, M., Vannucchi, A., Wilson, A., Göthert, J. R., Hanna, M., Jones, A., Peppe, J., Natsoulis, G., McClure, T., Hong, W.-J., Stevenson, W. S., Harrison, C. N., Talpaz, M., Vianelli, N., Rienhoff, H. Y.
Publicado 2022